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Methodologies to detect DNA sequences with high sensitivity and specificity have tremendous
potential as molecular diagnostic agents. Most current methods exploit the ability of single-
stranded DNA (ssDNA) to base pair with high specificity to a complementary molecule.
However, recent advances in robust techniques for recognition of DNA in the major and minor
groove have made possible the direct detection of double-stranded DNA (dsDNA), without the
need for denaturation, renaturation, or hybridization. This review will describe the progress in
adapting polyamides, triplex DNA, and engineered zinc finger DNA-binding proteins as dsDNA
diagnostic systems. In particular, the sequence-enabled reassembly (SEER) method, involving the
use of custom zinc finger proteins, offers the potential for direct detection of dsDNA in cells, with
implications for cell-based diagnostics and therapeutics.
An introduction to DNA diagnostics
Molecular diagnostics that report on DNA sequence informa-
tion are making increasingly important contributions to
medicine and research. Pathogen identification based on a
DNA sequence is more accurate, less subjective, and often
much faster than culture-based methods.1,2 In addition to
improving existing services, DNA diagnostics allow access to
genomic information previously unavailable to clinicians.
Genotyping methodologies, which reveal the status of the
single nucleotide polymorphisms (SNP) that distinguish one
individual’s genome from another’s, can provide insights into
the most effective drug regimen for a particular patient, or
provide clues to resistance or susceptibility for particular
diseases. Such diagnostic information can usually be obtained
by determining the presence, absence, or abundance of a
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particular known sequence. This feature distinguishes such
methods from general sequencing methodologies, which aim to
determine large stretches of unknown sequence.
Many types of DNA diagnostic methodologies have been
described. Some are in the very early stages of development
while others are commercially available. One approach to
categorize the myriad of techniques is to define how they
address their common goals. Like all diagnostic technology,
DNA diagnostics require both a detection method and a signal
transducer. Most current detection methods for the sequence-
specific recognition of DNA make use of the special property
of single-stranded DNA (ssDNA) to base pair with high
specificity to a complementary molecule (Fig. 1A). The other
molecule may be another ssDNA, ssRNA, peptide-nucleic acid
(PNA),3 or other base-pairing molecular analog. Such specific
annealing or hybridization forms the basis for such common
technologies as PCR amplification with specific primer sets,
Southern blot, Northern blot, DNA microarray, and fluor-
escent in situ hybridization (FISH).4 However, there are other
ways to read the sequence information besides Watson–Crick
base-pairing (Fig. 1B). For example, polyamides are small
chemical compounds that can be designed to bind with high
sequence specificity in the minor groove of double-stranded
DNA (dsDNA).5 Similarly, triplex-forming DNA,6 and zinc
finger DNA-binding proteins7 can all be engineered to achieve
specific base-pair recognition of dsDNA in the major groove.
The second component required is a signal transducer, which
converts the sequence-specific recognition event into a signal
that can be quantitatively measured (Fig. 1). Typically the
signal is optical (colorimetric, fluorescent, luminescent, turbi-
dic, etc) or electrical (voltage, resistance, or current change).
Transducers with fluorescent readouts are used most com-
monly, such as dyes that intercalate into dsDNA (ethidium
bromide and SYBR green) or are attached to the base-pairing
partner of ssDNA (labeled probes used in DNA microarrays,8
Taqman real-time PCR chemistry,9 or FISH). While the
specificity of a DNA diagnostic will depend on the fidelity of
the detection method, the sensitivity will largely be a function
of the signal transducer. For example, PNA probes can be
engineered to bind with extremely high specificity and affinity
to their denatured chromosomal targets in a FISH assay.10
However, detection of unique genomic sequences is limited by
the difficulty in detecting the weak signal of one fluorescent
molecule over background. To improve sensitivity, several
ingenious methods have recently been developed to sensitively
Fig. 1 An overview of DNA diagnostic methods. Detection methods
can read the sequence information by either (A) Watson–Crick base
pairing with one strand (orange), which requires denaturation of the
duplex and subsequent hybridization with a complementary probe
(purple), or (B) direct detection of dsDNA by specific interaction with
base edges in the major or minor groove. A signal transducer converts
the detection event into a quantitative signal, such as fluorescence
intensity (green).
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detect the recognition event (such as hybridization-dependent
current fluctuations across an a-hemolysin nanopore11,12), or
amplify the transduced signal (such as hybridization-depen-
dent release of barcode DNA from captured nanoparticles,13
or aggregation-enhanced fluorescence14). Some of these
methods have proven to be extremely sensitive, able to detect
molecules in the zeptomolar range (1–500 molecules per ml
sample). Other strategies rely again on the special ability of
nucleic acids to form specific base pairs and enzymatically
amplify the DNA, either before or as part of the detection
method (such as PCR, Strand Displacement Amplification
(SDA),15 or Rolling Circle Amplification (RCA)16).
For an overview of recent advances in hybridization-based
DNA diagnostics, the reader is directed to several outstanding
reviews on this topic.17–19 The scope of this review will be
restricted to methods for the direct detection of dsDNA,
meaning methods that do not require dsDNA denaturation
and subsequent hybridization. Progress in this area has been
slower because of the difficulty in engineering highly specific
detection methods for the major or minor groove of DNA.
However, the emergence of such technologies in the past
decade has now enabled their application as dsDNA diag-
nostics. In some cases, the ability to use dsDNA as a substrate
enables capabilities beyond what would be possible for
hybridization-based methods.
Beyond annealing: direct detection of dsDNA
Methods for direct detection of dsDNA in the minor groove
Polyamides. Structural studies on the polyamide antibiotics,
netropsin and distamycin A, demonstrated their sequence-
specific minor groove targeting capabilities.20 Dickerson and
Wemmer have demonstrated that distamycin A is capable of
binding as a homodimer in the minor groove by specifically
targeting AT-rich sequences. Building on these initial observa-
tions and by further synthetic, structural and biophysical
studies, Dervan and coworkers have developed a powerful
and general approach for the sequence-specific recognition
of the minor groove of dsDNA utilizing designed
hairpin polyamides, composed of N-methylpyrroles and
N-methylimidazoles (Fig. 2).5,21,22 These seminal studies have
allowed polyamides to emerge as a useful molecular recogni-
tion tool kit for sequence-specific targeting of dsDNA.
Laemmli and coworkers have recently utilized fluorescein-
labeled polyamides as ‘‘chromosome paints’’ with the goal to
visualize AT-rich satellite regions and scaffold-associated
regions in the genome of Drosophila melanogaster.23 In a
second study, designed polyamides conjugated to Texas-Red
were used to target and visualize telomeric repeats in insects
(TTAGG) and vertebrates (TTAGGG) with high specificity.24
These results demonstrated that telomere-specific polyamide-
dye conjugates might allow for the rapid estimation of the
telomere length. These elegant studies utilized fluorescence
microscopy of fixed cells or of isolated nuclei, where excess
labeled-polyamides can be removed. However, the detection of
dsDNA in live cells or whole animals would require a method
for removing unbound labeled-polyamides, as the background
fluorescence would likely decrease the contrast.
With the goal of lowering background (signal from unbound
labeled-polyamides), Dervan and coworkers have recently
designed and tested polyamides conjugated to intercalating
dyes tetramethyl rhodamine and thiazole orange (Fig. 2,
right).25,26 In these studies, several fluorescent conjugates
were synthesized and tested against dsDNA targets,
59-WGGGWW-39, 59-WGGCCW-39, and 59-WGWWCW-39
(W = A or T). It was found that the designed conjugates with
thiazole orange exhibit .1 000-fold fluorescence enhancement
only in the presence of specific target dsDNA, where the dye
likely intercalates at an adjacent site. The lowest concentration
of oligonucleotide detected in this study was 1 nM, although
lower concentrations were not examined. Mismatched targets
reduced the signal by .90%. As polyamide binding site sizes
and sequence specificities are being further refined, these new
dsDNA-sensitive dyes attached to appropriate targeting
molecules will likely find use in probing dsDNA in a cellular
setting.27
Methods for direct detection of dsDNA in the major groove
Triplex DNA. Triple helix-forming oligonucleotides (TFO)
bind to polypurine/polypyrimidine tracts in the major groove
Fig. 2 Polyamide minor groove binders. Left: structural representation of a polyamide (green) bound in the minor groove of dsDNA (black and
orange). Middle: a schematic illustration of the binding interactions. The abbreviations are pyrrole (Py), hydroxypyrrole (Hp), and imidazole (Im).
Right: chemical structure of thiazole orange, used as a signal transducer.
This journal is  The Royal Society of Chemistry 2006 Mol. BioSyst., 2006, 2, 551–560 | 553
of dsDNA (Fig. 3).28,29 Sequence-specific recognition is
achieved by Hoogsteen or reverse Hoogsteen hydrogen
bonding to purines in the major groove, thus restricting triplex
formation to sequences with purines on one strand.6 TFO
composed of polypurines bind in a direction antiparallel to the
purine strand of the duplex. However, G-rich TFO are
susceptible to forming competing G-quadruplex structures.30
TFO composed of polypyrimidines bind parallel to the purine
strand, however the cytosines must be protonated. The binding
of polypyrimidine TFO is therefore pH dependent, and does
not readily occur at physiological pH. 5-Methylcytosine is
often substituted for cytosine to improve affinity, but does not
avoid the requirement for protonation. TFO composed of
thymine and guanine bases are also frequently used. Unlike
polyamides, it is fairly trivial to make a 16–20 nt TFO, which
should have sufficient specificity to target a unique site in the
human genome.
An early application of triplex-DNA as a diagnostic agent
was to stain an alpha-satellite repeat in chromosomal spreads
using an assay analogous to FISH (appropriately termed
TISH).31 A 16 nt polypyrimidine TFO was designed to bind
the 500–1000 repeats of the target sequence at pH 6 without
denaturation. TFO binding was stabilized by crosslinking to
the duplex via a tethered psoralen moiety. Signal transduction
was accomplished by tagging the TFO with fluorescein
isothiocyanate (FITC). The study found TISH comparable
to FISH in both sensitivity and specificity. The dsDNA-based
TISH was suggested to be more quantitative than FISH, since
there was no competition between probe hybridization and
duplex reannealing. Additionally, non-denatured DNA
allowed TISH, but not FISH, to be compatible with
G-banding chromosomal reference techniques.
Another application of triplex DNA is the so called
‘‘padlock’’ TFO.32 The detection method is based on the
central part of a linear TFO, which forms a triplex with the
target duplex DNA. The ends of the linear molecule can be
joined covalently by base-pairing with an additional ‘‘splint’’
oligonuclotide, followed by DNA ligase (Fig. 3, top right). The
result is a circular ssDNA molecule that is topologically linked
to the target duplex. Signal transduction can be accomplished
by RCA,16 or other amplification method. The ends of the
TFO can alternatively be stabilized non-covalently by a stem-
loop structure (Fig. 3, bottom right).33,34 Signal transduction
in this case can be accomplished by designing the stem loop to
have a short terminal overhang, to which a fluorescently
labeled DNA can be ligated. Because the TFO is physically
wrapped around the duplex molecule (hence the name
‘‘padlock’’), the affinity of this complex is far greater than
that of the triplex alone. In one study, a polypurine/
polypyrimidine tract in individually spread molecules of
lambda phage DNA was visualized with a 59 nt stem-loop
oligonucleotide probe (containing a 15 nt central triplex
forming region) and a 500 bp stem-loop-binding labeled
duplex.33 For increased sensitivity, the 500 bp DNA was
labeled with at least 20 molecules of AlexaFluor 546. The
purified lambda DNA was stretched on glass slides using
molecular combing methods. The sample had to be heated to
unwind the stem-loop on the probe oligonucleotide, then
slowly cooled to allow rewinding after triplex formation. The
precise position of the target site along individual DNAs was
easily observable by fluorescence microscopy. In another
study, radiolabeled padlock TFO were able to detect
subfemtomolar concentrations of target dsDNA using a signal
transduction method of gel electrophoresis followed by
autoradiography of dried gels.34
A wide variety of technological improvements have been
made to expand recognition beyond strictly polypurine tracts,
improve affinity, reduce pH dependence, and reduce degrada-
tion in cells. For example, artificial base analogs can extend
recognition to all possible base pairs.35 Chemical compounds
such as BQQ can act as triplex stabilizing agents.36 Triplex
formation involving any sequence of bases was suggested to
occur at physiological pH in the presence of YOYO-1, an
oxazole yellow homodimer the fluorescent intensity of which
increases over 1 000-fold in the presence of dsDNA and
100 000-fold in the presence of triplex DNA.37 This approach
was reported to distinguish SNPs and single base pair deletions
in PCR amplified fragments of cystic fibrosis gene, the DNA
Fig. 3 Triplex-DNA major groove binders. Left: structural representation of a TFO (green) bound in the major groove of dsDNA (black and
orange). Middle: a schematic illustration of the binding interactions. Right: two types of ‘‘padlock’’ TFO strategies, (top) linear TFO with ends
joined using a ‘‘splint’’ oligonucleotide (blue), and (bottom) stem-loop TFO with ligated fluorescently labeled DNA (purple).
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repair gene hMSH2, and the tumor suppressor genes BRCA1
and P16. The assay was extremely rapid and simple; however,
the postulated triplexes were not unequivocally demonstrated.
Such modified triplex paradigms and their general applic-
ability for direct dsDNA recognition deserve further study.
Other triplex-like detection methods. Various other dsDNA
detection methods involve both interactions in the major and/
or minor groove as well as Watson–Crick base pairing
interactions accompanied by strand displacement. Two exam-
ples of such methods are RecA- and PNA-mediated dsDNA
complexes. The E. coli recombination protein RecA catalyzes a
homology-dependent strand invasion and exchange reaction in
which the invading strand ultimately becomes base-paired to
the complementary duplex strand. The initial recognition of
the homologous region is based on a triplex structure.38,39
Peptide nucleic acid (PNA) are synthetic nucleic acid
homologs containing standard DNA bases but a polyamide
backbone composed of N-(2-aminoethyl) glycine units. The
nucleobases are attached with methylenecarbonyl linkers.40
The neutral backbone eliminates the charge repulsion in
standard nucleic acid hybridization, therefore PNA is able to
bind DNA and RNA with extremely high affinity and
specificity. In the most common application, a homopyrimi-
dine PNA forms a structure in which one PNA molecule forms
Watson–Crick base pair interactions with a polypurine DNA
strand, while another PNA forms Hoogsteen interactions. The
other DNA strand is displaced, forming a ‘‘P loop’’. However,
a variety of PNA:DNA2, PNA2:DNA, PNA2:DNA2 structures
have been observed under various experimental conditions.3
DNA detection applications have been developed using both
RecA41 and PNA.42–44 Indeed, applications of PNA are so
numerous that the reader is directed to a dedicated review on
this subject.45 However, as both these technologies involve
some aspect of local duplex disruption and are not strictly
major or minor groove detection methods, they will not be
discussed further here.
Sequence-specific DNA-binding proteins. The most common
method for dsDNA recognition found in nature is the use of
sequence-specific DNA-binding proteins. The various tran-
scription factors, repair proteins, and DNA maintenance
enzymes (nucleases, topoisomerases, helicases) comprise one
of the largest functional groups encoded in the human
genome.46 Several proof-of-concept experiments explored the
coupling of the dsDNA detection capabilities of natural DNA-
binding proteins with a signal transduction system. In a study
similar to the polyamide experiments described earlier, a
50 residue peptide corresponding to the DNA-binding domain
of Hin recombinase was attached to the dye oxazole-yellow,
allowing for fluorescence enhancement only in the presence of
target dsDNA.47 In another study, the site-specific restriction
enzyme EcoRI was conjugated to 20 nm fluorescent nanopar-
ticles.48 In the absence of magnesium ions, EcoRI was able
to bind its target without subsequent cleavage. In an assay
similar to the padlock TFO described earlier, the EcoRI–
nanoparticle conjugates enabled direct visualization of EcoRI
sites on stretched single DNA molecules using fluorescence
microscopy.
Beyond in vitro assays, the E. coli lac repressor was fused to
green fluorescent protein (GFP) to visualize inserted repeats of
the lac operator in living yeast and mammalian cells.49 Single
chromosomal integrations of a vector containing 256 repeats
of the lac operator could be observed by fluorescence
microscopy in cells expressing the GFP–lac fusion protein,
with a signal-to-noise (background nuclear fluorescence) ratio
of 12 : 1. In the absence of DNA binding, the expression of
GFP–lac produced only diffuse fluorescence. The sensitivity of
this live cell imaging method was found to be comparable to
immunostaining and FISH. The study went on to demonstrate
the utility of this method to examine chromonema fibers in
interphase nuclei. The authors noted that previous failures to
appreciate large-scale chromatin substructure within chromo-
some domains were consistent with structural perturbations in
chromatin structure resulting from standard in situ hybridiza-
tion procedures. More recently, the GFP–lac system was used
to perform mosaic analysis in living C. elegans.50
The GFP–lac studies demonstrate successful detection in an
environment in which the direct detection of dsDNA is a clear
advantage, the living cell. However, these studies also illustrate
the technological challenges to advancing beyond the proof-of-
concept stage. First, the use of natural DNA-binding proteins
as the detection method severely restricts the spectrum of
DNA sequences that can be recognized. Second, signal
transduction was successful because 256 GFP–lac molecules
were spatially restricted to one locus. Detection of spatially
distributed or unique target sequences, as is more typically
desired, would be impossible because the individual bound
GFP–lac molecules would have the same signal intensity as
unbound molecules. We have attempted to address both of
these challenges in the recently described sequence-enabled
reassembly (SEER) detection methodology.51–53 As will be
described below, the detection method is based on engineered
zinc finger proteins, the specificity of which can be pro-
grammed by the investigator. The signal transducer is based on
the binding-dependent reassembly of a reporter protein, such
that no signal should be present unless DNA-binding occurs.
The SEER method for direct detection of dsDNA
Engineered zinc finger DNA-binding proteins. Cys2–His2 zinc
finger domains are the largest family of DNA binding domains
in the human genome.46 Each domain is a small peptide
consisting of 30 amino acids folded into a bba structure that is
stabilized by the chelation of a zinc ion to the two cysteine and
two histidine residues.54 The specificity of zinc fingers is
determined by the a-helix region, which is inserted into the
major groove of DNA where it contacts 3 or 4 bases. These
domains can exist as tandem repeats to form multi-finger
structures recognizing extended DNA sequences (Fig. 4). Zinc
fingers are highly specific and normally bind to DNA with
nanomolar to picomolar affinity.
Using phage display technology, DNA contacting amino
acids in the zinc finger domain were randomized for the
selection of new variants that recognize desired DNA
sequences.55,56 This allowed the selection of modules to
construct multi-domain zinc fingers to bind to specific DNA
sequences. Currently, domains have been identified that
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facilitate binding to all 59-GNN-39, most 59-ANN-39 and
59-CNN-39, and some 59-TNN-39 type sequences, enabling
targeting to an extremely wide spectrum of target sites.57–59
Multi-finger proteins based on these custom DNA binding
domains can be assembled by PCR using overlapping
oligonucleotides or commercial synthesis.60,61
SEER-GFP. Simply attaching a fluoresent molecule such as
GFP to an engineered zinc finger protein would probably
generate a useful reagent for visualizing repeated sequences.
Such a reagent would be similar to the polyamide paintbrush,
TISH, or GFP–lac fusions described above, and could be
targeted to biologically relevant repeated elements. However,
to visualize low copy number or unique sequences would
require a mechanism to reduce the background, that is, to
eliminate fluorescence in the absence of DNA binding.
Sequence-enabled reassembly of GFP (SEER-GFP)53 reduces
background through the convergence of custom-designed zinc
fingers and a split-protein system62 to create a ‘‘turn-on’’ DNA
biosensor (Fig. 5A). In the split-protein system, the GFP was
dissected into two fragments that were non-fluorescent, and
would not assemble to form the functional protein by
themselves without the assistance of dimerization domains.63
In SEER-GFP, the GFP fragments were fused to zinc fingers
via a 15 amino acid peptide linker. The hypothesis was that in
the presence of adjacent DNA sequences recognized by the
zinc fingers, the GFP fragments would be brought into
proximity for refolding into a functional fluorophore upon
DNA binding. The two proteins were purified and the
equimolar mixtures were incubated in the absence and
presence of oligonucleotide containing the target sites of the
zinc fingers separated by 10 bp. Fluorescent spectra were
obtained after 48 h, showing functional GFP only in the
presence of target oligonucleotides. No fluorescence was
detected when only one of the proteins was present, or when
the proteins were mixed with non-specific herring sperm DNA.
SEER-LAC. Sequence-enabled reassembly of b-lactamase
(SEER-LAC) was a modified version of SEER-GFP, such that
the GFP fragments were replaced by the antibiotic-resistant
Fig. 4 Zinc finger protein major groove binders. Top: structural representation of a three zinc finger protein (blue) bound in the major groove of
dsDNA (black and orange). Bottom: recognition modules incorporated into the alpha helix of a zinc finger that will enable it to specifically bind the
indicated 59-ANN-39, 59-CNN-39 or 59-GNN-39 DNA sequence.
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enzyme TEM-1 b-lactamase (Fig. 5B).51 This enzyme had
several attractive features for our studies. Because eukaryotic
cells do not contain an endogenous b-lactamase activity, a
signal generated from this enzyme was expected to have little
background. Its activity could be monitored both in vitro,
using the chromogenic substrate nitrocefin, and in vivo, using
the fluorescent substrates such as CCF2/AM or CC2.64 Like
GFP, fragments of TEM-1 b-lactamase had been generated
that could reassemble when attached to appropriate dimeriza-
tion domains.65 The constructs of SEER-LAC were similar to
that of SEER-GFP, where the lactamase fragments were
linked to zinc fingers via a 15 amino acid linker. SEER-LAC
required substrate to produce a signal when the correct DNA
sequences were present, making it possible to amplify the
intensity of the signal. This enzymatic system was a 1 000-fold
improvement in detection time over SEER-GFP, as it could
differentiate target from non-target DNA sequences in 5 min.
The colorimetric assay format had sufficient sensitivity to
easily detect 20 nM of purified target DNA. The specificity of
the system was high enough to distinguish a single base-pair
mutation in the 18 bp binding site. The intensity of the signal
remained the same in the presence of equal mass herring sperm
DNA to target oligonucleotide.
mCpG-SEER: detection of chemically modified DNA.
Beyond the catalogue of genes and their products in the
human genome, there exists a second level of complexity
comprising the carefully regulated chemical modification of
DNA and its associated proteins. DNA methylation plays a
central role in the epigenetic modification of genomic DNA
and directly regulates transcription and chromatin struc-
ture.66–68 The methylation of cytosine at the 59-position in
humans is the only documented epigenetic modification, which
is controlled by DNA methyltransferases, methyl-CpG binding
proteins, and a postulated DNA demethylase. Standard PCR
amplification of DNA from tissue samples, followed by either
sequencing or microarray detection cannot distinguish
between cytosine and methylated cytosine. The detection of
methylated CpG sites was revolutionized by the bisulfite
modification technique that converts unmethylated cytosine to
uracil but not methylated cytosine, thus allowing for dis-
crimination between methylated versus unmethylated sites.69,70
Bisulfite-modified DNA can be subsequently amplified by
PCR and analyzed by conventional sequencing or microarray
methods. Alternatively, bisulfite-modified DNA can be ana-
lyzed by methylation-specific PCR in which appropriate
primers are designed to selectively recognize and amplify
unmodified CpG-containing sites. The bisulfite method
requires denaturing double-stranded DNA and bisulfite
treatment for 4–18 h, followed by sequencing, microarray
detection, or methylation-specific PCR71 and their varia-
tions.72 Some problems arising from these approaches are:
(a) DNA occasionally partially degrades;73 (b) incomplete
bisulfite reactions result in false positives;74 (c) resulting single-
stranded DNA adopts alternate folded conformations75 that
prevent PCR amplifications; (d) primer design becomes
problematic in methylation-specific PCR; and (e) microarray
detection technologies are expensive.76 Many of the above
artifacts can be solved77 with appropriate changes in experi-
mental conditions, however the total time for this reaction and
Fig. 5 The SEER method for the direct detection of dsDNA. (A) SEER-GFP, (B) SEER-LAC, (C) mCpG-SEER with GFP.
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analysis is long and remains constant. Thus, an alternate
approach, independent of bisulfite treatment and PCR
amplification, that could rapidly detect the methylation status
of CpG islands in known promoter sites would be of
considerable benefit in this area.
Towards the goal of a rapid method for the detection of
known sites of hypermethylation at CpG islands, we have
recently developed a new approach called mCpG-SEER
(Fig. 5C).52 The mCpG-SEER system was designed based
upon our existing SEER-GFP system, while incorporating a
means for targeting methylated CpG sites. We chose the well-
characterized MBD2 protein from humans, that has a binding
affinity of 2.7 nM for mCpG sites while it has a 50–100 fold
reduced binding affinity for unmethylated CpG sites. We
hypothesized that this difference in binding affinities would
allow us to selectively target mCpG sites versus unmethylated
CpG sites. Since numerous sites on a genome are methylated,
we needed to introduce sequence selectivity, which can be
readily achieved by utilizing natural and designed zinc fingers
as discussed. As proof of concept, we employed the Zif268 zinc
finger to recognize a site next to the mCpG site. We found that
the specificity of mCpG-SEER was .40-fold between a
methylated versus a non-methylated CpG target site. We also
found that the fluorescent signal was linear to 5 pmol of
methylated target DNA in a 100 mL sample volume. Thus,
mCpG-SEER represents a new and potentially useful method
for the direct detection of CpG methylation, which may find
numerous applications in delineating the epigenome and in
cancer research.
Current status and future of direct detection methods
for dsDNA
Why is direct detection of dsDNA important?
DNA is rarely present in single-stranded form, either naturally
or after PCR amplification. Improvements in the detection of
either type of dsDNA should lead to more robust and flexible
DNA diagnostics. The dsDNA-based TISH was suggested to
be more quantitative than FISH, since there was no competi-
tion between probe hybridization and duplex reannealing.31
Also, perturbations in chromatin structure may result from
standard in situ hybridization procedures.49 Several of the
assays described were extremely fast and simple, requiring no
duplex denaturation or careful control of temperature.
Conceivably, such methods could reduce assay time as well
as the costs associated with sophisticated instrumentation and
highly-trained technicians.
Into the cell
Direct detection of dsDNA would also have an obvious
advantage for the visualization of genomic information in
living cells. Methods for determining genotype, chromatin
status, and target copy number in individual living cells have
been largely inaccessible using currently available hybridiza-
tion-based techniques.78 Triplex DNA, polyamides and
engineered zinc finger proteins have all been used in cells with
some efficacy as gene regulators79 and inducers of DNA
damage or homologous recombination.80 Therefore, they are
good candidates for cellular diagnostic assays, although none
have yet been evaluated in this role. Table 1 compares several
features of the methods described in this review. Methods such
as fluorescein-conjugated polyamides or triplex (TISH) could
be applied to visualize repeated regions in living cells.
Background fluorescence would be expected to be high, but
the GFP–lac study suggests binding to spatially restricted loci
might generate sufficient signal. Methods such as Thiazole
orange-polyamides or SEER should have less background,
and therefore should be even more sensitive. However, the
sensitivity of all these methods will likely need to be improved
in order to detect unique sequences in cells, such as SNPs,
translocations, or mutations.
Beyond detection
While any of these methods might eventually be suitable for
dsDNA detection, SEER offers several additional capabilities.
The ability to use other types of DNA-binding domains
enables the recognition of other types of information, such as
DNA methylation (mCpG-SEER), adducts and damage. In
cells, the ability to reassemble enzymatic functions in response
to genotype could have applications for gene therapy. Also,
the use of cytotoxic substrates81 or enzymes in cells could
Table 1 Methods for direct detection of dsDNA
Method Assay Sensitivity Sequence restrictions Likely to be useful in cells Reference
Polyamide:
Fluorescein conjugate FISH-like Highly repeated sequences None Yes 23,24
Thiazole orange Oligo targets 1 nMa None Yes 25
Triplex:
TISH FISH-like Highly repeated sequences Polypurine tracts Yes 31
Padlock-FITC Spread molecules Single molecule Polypurine tracts No, heat requirement 33
Padlock-radiolabeled Southern ,1 fM Polypurine tracts No, heat requirement 34
YOYO-1 Amplified DNA 4 nMa None No, intercalator 37
Protein:
Hin-oxazole yellow Oligo targets 50 nMa Hin sites Delivery? 47
EcoRI–nano Spread molecules Single molecule EcoRI sites No, cleavage 48
GFP–lac Live cell 256 tandem repeats lac sites Yes 49
SEER-GFP Oligo targets 2.5 mMa Few Yes 53
SEER-LAC Oligo targets 20 nM Few Yes 51
mCpG SEER Oligo targets 50 nM Few Yes 52
a Lowest concentration used in study, but lower concentrations were not examined.
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enable sequence-dependent cell killing, with applications for
therapeutics.
Conclusions
If the field of DNA diagnostics is in its infancy, methods for
the direct detection of dsDNA are embryonic. Most of the
recent work is still proof-of-concept experiments. This is
partially technological. TFO have been used since the 1980s,
polyamides were developed in the mid 1990s and the first
generally accessible methods for engineering zinc finger
proteins were described in 1999. Polyamides have the least
sequence recognition restrictions, but are generally limited to
short (i.e. multiple) target sites. TFO can recognize long (i.e.
unique) target sites, but are generally limited to polypurine
tracts. Engineered zinc finger proteins can be designed to long
target sites with less sequence restrictions, but are still
currently unable to target all possible sequences. However,
the pace and scope of new investigations continued to increase,
and some promising candidate methods (such as triplex with
YOYO-1) are already entering commercial development. The
field is benefiting from intensifying research in other applica-
tions of dsDNA recognition technology, primarily in the areas
of gene regulation and gene disruption/correction. There is
also a growing consensus to bridge the gap between the basic
scientists who develop these methods but are unfamiliar with
their applications, and the clinicians who would use these
methods but are unfamiliar with the technological challenges.
The greatest progress will certainly be made by the collabora-
tion between these two camps.
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